Fulgent Genetics Depreciation & Amortization 2011-2026 | FLGT

Annual Depreciation & Amortization Fulgent Genetics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
24.9 M	26.1 M	32.7 M	11 M	2.96 M	2.11 M	2.16 M	1.73 M	1.17 M	575 K	196 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
32.7 M	196 K	9.6 M

Quarterly Depreciation & Amortization Fulgent Genetics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.9 M	3.9 M	5.92 M	-	3.8 M	4 M	6.66 M	-	6.42 M	6.31 M	6.88 M	-	7.6 M	6.6 M	4.7 M	911 K	7.51 M	2.3 M	1.92 M	-	1.84 M	1.12 M	569 K	-	503 K	511 K	535 K	-	547 K	562 K	516 K	-	438 K	405 K	412 K	-	304 K	248 K	199 K	-	171 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
7.6 M	171 K	2.76 M

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Co-Diagnostics CODX	1.11 M	$ 1.31	-19.63 %	$ 1.74 M	USA
Agilent Technologies A	321 M	$ 112.11	-1.0 %	$ 34.1 B	USA
Castle Biosciences CSTL	40.8 M	$ 19.11	1.19 %	$ 554 M	USA
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	112 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
Illumina ILMN	354 M	$ 142.72	-0.36 %	$ 22.7 B	USA
Interpace Biosciences IDXG	425 K	$ 1.8	-	$ 7.96 M	USA
CareDx, Inc CDNA	15 M	$ 19.85	-3.12 %	$ 1.06 B	USA
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	70.1 M	$ 93.78	-2.99 %	$ 6.33 B	USA
Medpace Holdings MEDP	27.2 M	$ 418.32	-0.2 %	$ 12.1 B	USA
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
Mettler-Toledo International MTD	51.1 M	$ 1 038.75	-0.3 %	$ 21.4 B	Schweiz
Myriad Genetics MYGN	53.7 M	$ 3.62	-	$ 335 M	USA
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
NeoGenomics NEO	36.1 M	$ 8.29	-0.9 %	$ 1.06 B	USA
Charles River Laboratories International CRL	403 M	$ 152.19	-4.36 %	$ 7.54 B	USA
National Research Corporation NRC	7.62 M	$ 18.61	-1.69 %	$ 417 M	USA
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	16.7 M	$ 188.15	-4.45 %	$ 18.5 B	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
Koninklijke Philips N.V. PHG	1.12 B	$ 25.27	-0.96 %	$ 24 B	Niderland
Guardant Health GH	39.7 M	$ 94.27	-4.45 %	$ 11.8 B	USA
Personalis PSNL	10 M	$ 6.38	-4.92 %	$ 569 M	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
ICON Public Limited Company ICLR	488 M	$ 116.56	-0.45 %	$ 9.61 B	Irlanda
Senseonics Holdings SENS	1.51 M	$ 5.72	-1.72 %	$ 239 M	USA
Soleno Therapeutics SLNO	2.02 M	$ 53.0	0.01 %	$ 2.69 B	USA
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Biomerica BMRA	87 K	$ 2.25	-6.67 %	$ 5.17 M	USA
Laboratory Corporation of America Holdings LH	681 M	$ 252.68	-0.53 %	$ 21 B	USA
Thermo Fisher Scientific TMO	1.05 B	$ 438.85	-2.07 %	$ 165 B	USA
Celcuity CELC	167 K	$ 135.17	0.33 %	$ 6.32 B	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
Twist Bioscience Corporation TWST	24.9 M	$ 48.65	-8.12 %	$ 2.91 B	USA
Neogen Corporation NEOG	119 M	$ 8.21	-2.61 %	$ 1.78 B	USA
Quest Diagnostics Incorporated DGX	570 M	$ 187.55	-0.21 %	$ 20.8 B	USA
Invitae Corporation NVTA	142 M	-	-	$ 21.2 M	USA